ZBNA
KURA icon

Zions Bancorporation, National Association’s Kura Oncology KURA Stock Holding History

Zions Bancorporation, National Association’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-110
Closed -$1.14K – 1561
2025
Q4 		$1.14K Buy
+110
New +$1.15K ﹤0.01% 1074

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zions Bancorporation, National Association's KURA Position: Q1 2026 in Review

Zions Bancorporation, National Association sold out of Kura Oncology (KURA) in Q1 2026, closing a stake of 110 shares — an estimated $1.14K sold.

Zions Bancorporation, National Association first reported a position in KURA in Q4 2025 and held it in 1 quarter. The position peaked at $1.14K in Q4 2025. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Zions Bancorporation, National Association reported no remaining Kura Oncology position as of Q1 2026 after selling out during the quarter.
  • Zions Bancorporation, National Association sold 110 Kura Oncology shares in Q1 2026, an estimated $1.14K.
  • Zions Bancorporation, National Association first reported a position in Kura Oncology in Q4 2025 and held it in 1 quarter.
  • Zions Bancorporation, National Association's Kura Oncology position peaked at $1.14K in Q4 2025.
  • 222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q1 2026, filed 8 May 2026.